Stock listing
05Y Stock Price, News, Filings & Events — Vivoryon Therapeutics N.v.
Selected listing: 05Y · GETTEX · EUR · DE
This page tracks Vivoryon Therapeutics N.v.'s 05Y:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 05Y:GETTEX. 05Y:GETTEX is the stock-level entry point for investors researching Vivoryon Therapeutics N.v., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 05Y:GETTEX
- Asset type
- Stock
- Market cap
- $39.3M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- GETTEX
- Currency
- EUR
Vivoryon Therapeutics N.v. 05Y:GETTEX stock context
This page tracks Vivoryon Therapeutics N.v.'s 05Y:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 05Y:GETTEX. 05Y:GETTEX is the stock-level entry point for investors researching Vivoryon Therapeutics N.v., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Vivoryon Therapeutics N.v.
Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026
August 18, 2026
Vivoryon Therapeutics N.V. to Report H1 2026 Financial Results and Business Updates on August 6, 2026; Annual General Meeting Planned for...
July 22, 2026
Vivoryon Therapeutics N.V. to Report Q1 2026 Financial Results on June 11, 2026
June 8, 2026
Vivoryon Therapeutics N.V. Reports Full Year 2025 Financial Results and Provides Business Update
April 23, 2026
Vivoryon Therapeutics N.V. to Report Full Year 2025 Financial Results and Business Updates on April 23, 2026
April 15, 2026
Vivoryon Therapeutics N.v. earnings calls
Research Vivoryon Therapeutics N.v.
Vivoryon Therapeutics N.v. investor report
Review AI stock analysis and investor report context for 05Y:GETTEX.
Vivoryon Therapeutics N.v. company profile
View the public company page for Vivoryon Therapeutics N.v. on 6ix.
Vivoryon Therapeutics N.v. news
Read company news and market updates connected to Vivoryon Therapeutics N.v..
Vivoryon Therapeutics N.v. investor events
Find investor webinars, events, and replay context for Vivoryon Therapeutics N.v..
Alternate listings
VVY:EURONEXT
NL · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is 05Y:GETTEX.
05Y:TRADEGATE
DE · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is 05Y:GETTEX.
A2QJV6:LS
DE · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is 05Y:GETTEX.
0R3M:LSE
GB · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is 05Y:GETTEX.
05Y:FWB
DE · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is 05Y:GETTEX.
A2QJV6:LSX
DE · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is 05Y:GETTEX.
VVYA:AQUISEU
GB · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is 05Y:GETTEX.
VVYA:AQUISUK
GB · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is 05Y:GETTEX.
05Y:SWB
DE · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is 05Y:GETTEX.
VVYA:TURQUOISE
GB · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is 05Y:GETTEX.
05Y:DUS
DE · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is 05Y:GETTEX.
05Y:HAM
DE · EUR
Alternate listing for Vivoryon Therapeutics N.v.; the primary context on this page is 05Y:GETTEX.